Dietary change may boost energy in lymphoma survivors
NCT ID NCT06047626
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a diet rich in whole grains, vegetables, fruit, and fatty fish can reduce persistent fatigue in lymphoma survivors. One hundred participants will receive either the special diet counseling or general health advice over 3 months. The goal is to see if the diet improves energy, sleep, and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Fatigue Reduction Diet (FRD) - a diet rich in whole grains, vegetables, fruit, and fatty fish
- What this could lead to
- If it works, this could offer a simple, drug-free way to reduce fatigue and improve sleep and quality of life for lymphoma survivors.
- What could go wrong
- This is a small, early-stage study (100 people) testing a dietary change, which can be hard to stick with. Results may not apply to everyone, and the diet might not reduce fatigue more than general healthy eating advice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Michigan
RECRUITINGAnn Arbor, Michigan, 48109, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can engineered immune cells tackle brain lymphoma?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a targeted pill boost Chemotherapy's punch against lymphoma?